Osaic Holdings
DRUG

Osaic Holdings’s Bright Minds Biosciences DRUG Stock Holding History

Osaic Holdings’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-371
Closed -$29K – 7878
2025
Q4 		$29K Buy
+371
New +$24.8K ﹤0.01% 5611
2025
Q1 		– Sell
-175
Closed -$6.3K – 7509
2024
Q4 		$6.3K Buy
+175
New +$6.16K ﹤0.01% 6064
2022
Q4 		– Sell
-80
Closed – – 7235
2022
Q3 		$0 Buy
+80
New +$519 ﹤0.01% 7304

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Osaic Holdings's DRUG Position: Q1 2026 in Review

Osaic Holdings sold out of Bright Minds Biosciences (DRUG) in Q1 2026, closing a stake of 371 shares — an estimated $29K sold.

Osaic Holdings first reported a position in DRUG in Q3 2022 and held it in 3 quarters. The position peaked at $29K in Q4 2025. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Osaic Holdings reported no remaining Bright Minds Biosciences position as of Q1 2026 after selling out during the quarter.
  • Osaic Holdings sold 371 Bright Minds Biosciences shares in Q1 2026, an estimated $29K.
  • Osaic Holdings first reported a position in Bright Minds Biosciences in Q3 2022 and held it in 3 quarters.
  • Osaic Holdings's Bright Minds Biosciences position peaked at $29K in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.